Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Ruby Tsang summarises a recent longitudinal study of trajectories of inflammation in youth and risk of mental and ...

During winter, people typically see higher rates of mood decline from adjusting to the time change and reduced hours of ...

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

They are most helpful for people with the following conditions: Depression plus pain due to fibromyalgia, nerve pain, or irritable bowel syndrome Severe depression Anxiety disorders like GAD or panic ...

Many people get the “winter blues,” a mild sadness as the days get colder and shorter. But some people experience clinical ...

A recently published case report in the Journal of Psychosexual Health describes a surprising and unusual side effect ...

IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...

If you suspect you have postpartum depression, you can take the Edinburgh Postnatal Depression Scale, a short screening test ...

Good morning! Citi chief Jane Fraser gets a big pay bump, Kelly Loeffler is confirmed to lead the Small Business ...

Zoloft (sertraline) has interactions with many types of medications, including other antidepressants, amphetamines, blood thinners, and more.

Scientists think ketamine relieves depression and anxiety by altering GluN1-2B-2D’s movements, but the effects can vary ...